2020
DOI: 10.31344/ijhhs.v5i2.263
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of serum Ischemia Modified Albumin (IMA) Levels in Acute Rheumatic Fever

Abstract: Introduction : Rheumatic fever (RF) is an autoimmune, multiorgan inflammatory disease. The patients develop carditis (50-78%), arthritis (35-88%), chorea (2-19%), erythema marginatum (< 6%) and subcutaneous nodules (< 1-13%). Ischemia modified albumin or cobalt binding albumin is one of new biomarker for inflammation and oxidative stress. Various previous studies indicate that acute rheumatic fever is associated with oxidative stress and inflammation. In the present study, we examined IMA, CRP, ESR and a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…The current objective of RA treatment is to suppress inflammation, pain, and prevent bone destruction. While the symptoms of RA are similar to those of other types of arthritis, such as Rheumatic Fever, Arthralgia, gouty arthritis, and they all have a high rate of morbidity and disability, it is important to distinguish between them 2,3,4 .Both doctors and patients are misled about the disparities in diagnostic capabilities and treatment options available to them 5 . It is critical to comprehend the disease at the molecular level, specifically at the amino acid level, in order to provide correct diagnosis and therapy options.…”
Section: Introductionmentioning
confidence: 99%
“…The current objective of RA treatment is to suppress inflammation, pain, and prevent bone destruction. While the symptoms of RA are similar to those of other types of arthritis, such as Rheumatic Fever, Arthralgia, gouty arthritis, and they all have a high rate of morbidity and disability, it is important to distinguish between them 2,3,4 .Both doctors and patients are misled about the disparities in diagnostic capabilities and treatment options available to them 5 . It is critical to comprehend the disease at the molecular level, specifically at the amino acid level, in order to provide correct diagnosis and therapy options.…”
Section: Introductionmentioning
confidence: 99%
“…2,12 To prevent the ALI onset or recurrence or the CLI development, long-term use of antiaggregant -in case of vessel atherosclerosis -or anticoagulant prophylaxis in case of cardiac arrhythmias or previous episodes of thrombosis. 2,13 The study aims to analyze predictors of the occlusive thrombosis with the acute lower limb ischemia development (ALLI), under the specifically recommended prophylaxis.…”
Section: Introductionmentioning
confidence: 99%